Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CURIS INC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
7.53
9.9
10.4
10
10.8
10.6
10.2
10
10.9
9.44
Research and development
18
45.1
24.4
22.3
23.1
34.9
43.3
39.5
38.6
28.3
General and administrative
15.6
14.1
14.8
11.6
12.1
17.3
19.6
18.6
16.8
14
Operating income
-58
-49.8
-29.3
-24.4
-24.9
-42.1
-53
-48.3
-44.5
-5.71
Interest expense
2.78
3.97
3.93
0.79
0
0
Interest income
0.41
0.51
0.68
0.61
0.06
0.21
1.12
2.94
1.77
0.32
Other non-operating income
-2.37
-3.56
-3.24
-7.79
-5.01
-3.37
-3.65
0.92
1.15
-1.87
Income tax
0
0
Net income
-60.4
-53.3
-32.6
-32.1
-29.9
-45.4
-56.7
-47.4
-43.4
-7.58
EBITDA
-57.8
-49.5
-29.2
-24.2
-24.8
-41.9
-52.8
-48.1
-44.3
-5.54
EPS, basic
-2.25
-1.79
-0.98
-0.97
-0.61
0.50
-12.14
-8.96
-6.88
-0.58
EPS, diluted
-2.25
-1.79
-0.98
-0.97
-0.61
0.50
-12.14
-8.96
-6.88
-0.58
Shares, basic (weighted)
26.6
29.8
33.1
33.2
48.7
91.6
4.67
5.29
6.31
13.2
Shares, diluted (weighted)
26.6
29.8
33.1
33.2
48.7
91.6
4.67
5.29
6.31
13.2
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
26
38.3
23.6
15.4
130
40
19.7
26.7
20
5.06
Short-term investments
18.4
21.9
0.63
5.11
38.9
75.9
66
29.7
0
Receivables
2.46
3.07
2.86
3.24
3.04
3.22
2.98
2.79
3.35
0
Other current assets
1.26
0.99
0.83
1.06
1.22
3.27
3.52
1.78
3.04
1.85
Total current assets
48.2
64.3
28
25
173
122
92.1
60.9
26.4
6.92
Property, plant and equipment
0.41
0.37
0.27
0.15
0.66
0.51
0.69
0.43
0.23
0.06
Lease right-of-use assets
0.15
6.58
5.75
4.4
3.06
3.16
1.89
Goodwill
8.98
8.98
8.98
8.98
8.98
8.98
8.98
8.98
8.98
8.98
Long-term investments
0
14.6
24
0
Other non-current assets
0
0
0
0
0
0
2.02
3.36
1.96
1.57
Total assets
57.8
73.8
37.4
35.1
204
162
109
77.3
41.3
20
Accounts payable
5.88
5.42
2.91
4.47
4.17
6.42
3.19
3.17
3.02
5.61
Accrued liabilities
2.73
2.79
3.46
1.91
3.63
6.34
5.68
9.04
7.11
7.27
Deferred revenue
0
Short-term debt
4.94
5.92
6.92
0
0.56
0
8.5
7.56
0
Total current liabilities
13.5
14.1
13.3
6.54
10.1
13.4
10
22
19
14.1
Long-term debt
14.9
35.7
28.6
0
0.33
Lease liabilities
0
5.04
4.36
2.8
1.49
1.62
0.43
Other non-current liabilities
0.02
0.03
0.01
0
0.33
0
Total liabilities
28.5
49.8
41.9
69
73.7
71.6
62.3
57.6
47.3
14.5
Total debt
19.9
41.6
35.5
0
0.89
0
8.5
7.56
0
Paid-in capital
928
977
980
983
1,177
1,182
1,196
1,216
1,234
1,253
Retained earnings
-899
-952
-985
-1,017
-1,047
-1,092
-1,149
-1,196
-1,240
-1,247
Treasury stock
-1.52
-1.52
0
Other comprehensive income
-0
-0
0
0
-0
-0.11
-0.19
0.23
0
Shareholders' equity
29.5
24
-4.5
-33.9
131
90.7
46.6
19.7
-6
5.46
Total equity
29.5
24
-4.5
-33.9
131
90.7
46.6
19.7
-6
5.46
Total liabilities and equity
57.8
73.8
37.4
35.1
204
162
109
77.3
41.3
20
Shares outstanding
28.2
32.8
33.2
33.2
91.5
91.6
4.83
5.89
8.49
0.65
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-60.4
-53.3
-32.6
-32.1
-29.9
-45.4
-56.7
-47.4
-43.4
-7.58
Depreciation and amortization
0.19
0.24
0.18
0.13
0.14
0.16
0.23
0.26
0.2
0.17
Stock-based compensation
4.33
5.36
3.94
2.66
2.7
5.28
6.75
6
5.93
4.02
Change in receivables
-0.35
-0.61
0.21
-0.38
0.2
-0.18
0.25
0.18
-0.56
-1.03
Change in payables
2.32
-0.38
-1.87
0.06
1
4.97
-3.88
3.34
-2.08
2.55
Cash from operations
-35.8
-48.4
-30.1
-26.2
-25.7
-37.6
-54.3
-38.4
-39.6
-27.2
Capital expenditures
-0.33
-0.19
-0.09
-0.04
-0.68
0
-0.42
0
Purchases of investments
-57.6
-51.1
-26.7
-11.5
-53.4
-93.1
-62
-70.3
-18.1
0
Sales and maturities of investments
88.1
47.7
48.2
7.05
5.08
45.2
95.4
108
47.5
0
Cash from investing
30.1
-3.63
21.4
-4.46
-49
-47.9
33
37.8
29.4
2.5
Debt issued
0
0.89
0
Debt repaid
-4.27
-4.95
-6.1
-1.83
0
0
Stock issued
0
41.5
0
0
159
0
5.84
14.1
12
15.4
Cash from financing
-1.37
64.2
-5.96
23.3
189
-4.17
0.87
7.58
3.44
9.77
Net change in cash
-7.05
12.3
-14.7
-7.39
114
-89.7
-20.4
6.93
-6.68
-14.9
Free cash flow
-36.1
-48.5
-30.2
-26.2
-26.4
-37.6
-54.8
-38.4
Interest paid
2.79
3.94
3.92
4.72
5.05
4.44
4.11
2.36
0.46
1.53
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.83 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-203.2%
Operating income / revenue.
EBITDA margin
-201.2%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
-490.3%
Net income / revenue.
Operating cash flow margin
-709.0%
Cash from operations / revenue.
Return on equity (ROE)
-450.5%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-111.5%
Net income / average total assets.
R&D / revenue
589.2%
Research and development expense / revenue.
Stock-based pay / revenue
66.4%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
1.9%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-13.4%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-2.4%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-2.7%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value CAGR, 3y
-51.0%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-47.0%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-51.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-43.2%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-37.2%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
108.7%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
41.3%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
-23.0%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.49x
Current assets / current liabilities.
Quick ratio
0.37x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.37x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$2.02
Revenue / diluted weighted shares.
Operating cash flow per share
-$14.32
Cash from operations / diluted weighted shares.
Book value per share
$2.41
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.40x
Market cap / revenue.
P/B
0.37x
Market cap / shareholders' equity. Only when equity is positive.
Earnings yield
-1,220.0%
Net income / market cap (the inverse of P/E).
What was CURIS INC's revenue in fiscal 2025?
CURIS INC reported revenue of $9.4M for fiscal 2025, 13.4% lower than the year before.
Was CURIS INC profitable in fiscal 2025?
No. It reported a net loss of $7.6M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.